🇺🇸 FDA
Patent

US 9341626

Selective cytopheresis devices and related methods thereof

granted A61KA61K31/34A61P

Quick answer

US patent 9341626 (Selective cytopheresis devices and related methods thereof) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/34, A61P, A61P1/00, A61P1/04